Covance Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro Forma EPS Growth of 21.5% to $0.95 and Adjusted Net Orders of $773 Million
TFS, Top Sweden-Based Contract Research Organization, Selects OmniComm(R) TrialMaster(R) for Global Clinical Trial Research
Rich Pharmaceuticals Hires Contract Research Organization to File NDA and Identify Clinical Trial Site(s) for Lead Compound
Horizon Discovery and Otsuka Pharmaceutical Development and Commercialization Sign Collaboration Agreement
ICON and the University of Cambridge Collaborate to Deliver Educational Programme on Pricing & Market Access Strategy
National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS
Basilea to launch Zevtera(R)/Mabelio(R) (ceftobiprole medocaril) in Europe through a commercial services provider
Cancer Research UK is using Onyx Scientific to manage several of its drug development projects in a bid to maximise value for the UK's leading cancer charity. The UK-based contract research...